Dominican Republic vs Kenya: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Dominican Republic
87.0%
in 2025
Kenya
87.0%
in 2025
Dominican Republic rank
86th
Kenya rank
86th
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Dominican Republic
- Kenya
How they compare
Dominican Republic currently reports 87.0% against 87.0% in Kenya, a difference of 0.0%.
Across all 18 years both countries report, Kenya has been ahead every year.
Dominican Republic ranks 86th and Kenya ranks 86th of 194 countries.
Kenya has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Dominican Republic | Kenya | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 27.6% | 75.1% | 47.5% | Kenya |
| 2020s | 79.7% | 91.0% | 11.3% | Kenya |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Dominican Republic or Kenya?
- Dominican Republic, at 87.0% against 87.0% in Kenya as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Dominican Republic and Kenya?
- 0.0%, with Dominican Republic ahead.
- How many years of comparable data are there for Dominican Republic and Kenya?
- 18 years are reported by both, from 2008 to 2025.
- How do Dominican Republic and Kenya rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Dominican Republic ranks 86th and Kenya ranks 86th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.